BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Sucampo Pharmaceuticals, Inc. Release: Phase 3 Long-Term Safety Trial Results of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation was Recently Published in Alimentary Pharmacology and Therapeutics

  March 6, 2012

   · 

  6 min read
• Pharm Country

  Intellect Neurosciences, Inc. Receives Notice of Allowance from United States Patent and Trademark Office for its ANTISENILIN(R) Alzheimer’s Disease Immunotherapy Technology Platform

  March 6, 2012

   · 

  5 min read
• Pharm Country

  Third U.S. Patent Issued for Absorption Systems’ CellPort Technologies

  March 6, 2012

   · 

  3 min read
• TTP LabTech Ltd. Demonstrates Strong Analytical & Automation Offering at Pittcon 2012

  March 6, 2012

   · 

  1 min read
• Lone Star Bio

  Vermillion Receives Category 1 CPT Code Approval for OVA1

  March 6, 2012

   · 

  3 min read
• Genetown

  Schwartz Center Receives $500,000 Grant from the Amgen Foundation

  March 6, 2012

   · 

  5 min read
• BioForum: Biosimilars - Pioneering the Future

  March 6, 2012

   · 

  2 min read
• Frost & Sullivan: Electronically Enhanced Healthcare Fosters Improved Healthcare Delivery in EMEA Countries

  March 6, 2012

   · 

  3 min read
• BioCapital

  Butamax Expands Robust Isobutanol Patent Portfolio

  March 6, 2012

   · 

  1 min read
• NanoSight Limited Webinar Addresses the EU Definition of Nanomaterials 21st March 2012

  March 6, 2012

   · 

  4 min read